Strategic advice from experts you trust

drug costs

Welcome to the Gist Blog, where we share our thinking on healthcare trends and key issues facing the industry, and provide actionable guidance for CEOs and senior executives.

For more insights like these, subscribe to the Weekly Gist, an executive-level analysis of the week’s news delivered your inbox every Friday.

Understanding Medicare’s New Drug Proposals

We asked our friend and colleague Layne Oliff, who knows the Medicare pharmacy space well, to share an overview of the recent changes to Medicare Part D and Medicare Advantage pharmacy proposed by CMS, as well as his views on the impact of the proposal on providers
Read More

Subscribe to the Weekly Gist for executive-level commentary and insights from the week in healthcare, delivered to your inbox every Friday